chartexchange

PLRX
Pliant Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 2:34:58 PM EST
0.62USD-6.762%(-0.05)396,212
0.5600Bid0.7500Ask0.1900Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
South San Francisco, CA, USA
Previous Close
$0.66
Beta
0.91
52-Week High
$1.67 2025-12-04
52-Week Low
$0.64 2026-11-18
SMA 50
$0.95
SMA 200
$1.13
Avg. Vol 10D
554,545
Avg. Vol 30D
419,327
Avg. Vol 90D
422,126
Relative Vol
0.94
55.03M
0.4300%
5,100,000
4,863
Dec 4, 2000 · 1-for-8 (reverse)
PLRX Profile

pliant therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. by harnessing the therapeutic potential of integrin biology and tgf-β modulation, pliant aims to prevent or even reverse fibrosis to address the needs of many patients. the company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. pliant's co-founders include world-renowned researchers from university of california, san francisco (ucsf), who bring broad experience in fibrosis biology and small molecule chemistry. together, the pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.

PLRX Performance
PeriodPriceDateChangeBeta
1W0.742026-11-12-16.73%-1.154
1M0.902026-10-19-31.43%0.550
3M1.172026-08-19-47.33%1.110
6M1.152026-05-19-46.42%0.705
1Y1.502025-11-19-58.92%0.908
2Y12.792024-11-19-95.18%—
5Y15.002021-11-19-95.89%0.982
PLRX Stock Summary

Pliant Therapeutics, Inc. Common Stock (NASDAQ:PLRX) stock price today is $0.62, and today's volume is 394,206. PLRX is down 6.778% today. The 30 day average volume is 419,327. PLRX market cap is $38.20M with 61.99M shares outstanding.